Moronal (Nystatin)

Nystatin binds specifically to ergosterol in fungal cell membranes, creating pores that increase membrane permeability. This leads to leakage of essential intracellular components, loss of cellular integrity, and ultimately death of the fungal cell while sparing human cells that lack ergosterol.

The dosage and frequency of Moronal are determined by the prescribing healthcare professional based on the type and severity of the infection, patient age, and site of application. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical nystatin in pregnancy and lactation are limited. Because systemic absorption is minimal, it is generally considered low risk, but the prescriber should evaluate the benefit‑risk balance for each individual and advise accordingly.

To request Moronal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Moronal (nystatin) is a polyene antifungal that acts by binding ergosterol, whereas many azole creams inhibit ergosterol synthesis. Nystatin is effective for Candida species and has a low risk of systemic toxicity, making it suitable for localized infections, while azoles may have broader spectrum but higher potential for drug‑drug interactions.

Moronal should be stored at room temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency.

Moronal is applied topically to the affected skin area, typically in a thin layer, after cleaning and drying the site. The prescriber will specify the frequency, often two to three times daily, and the duration of treatment based on clinical response.

Serious risks, though rare, include allergic reactions such as hives, swelling, or severe contact dermatitis. If any signs of systemic involvement, such as unexplained liver dysfunction, occur, the product should be discontinued and medical evaluation sought immediately.

Moronal should not be used on extensive broken skin, mucous membranes, or the eyes. Individuals with known hypersensitivity to nystatin or any component of the formulation should avoid its use. Consultation with a healthcare professional is essential before starting treatment.